skin cancer: be more common in later life

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents tumor
Weight: 0.71
, hair
Weight: 0.69
, illness
Weight: 0.68
, cancer
Weight: 0.66
Siblings lung cancer
Weight: 0.84
, melanoma
Weight: 0.70
, colon
Weight: 0.56
, prostate cancer
Weight: 0.41
, liver cancer
Weight: 0.40

Related properties

Property Similarity
be more common in later life 1.00
be more common in life 0.92
be more common in people 0.86
be more common in people with skin 0.82
be more common in people with lighter skin 0.80
is most common 0.80
be more common in people with tone 0.79
is common 0.79
be more common in people with lighter tone 0.78
be more prevalent today 0.76

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Plausibility inference from child typicality

0.37
Rule weight: 0.66
Evidence weight: 0.71
Similarity weight: 0.79
Evidence: 0.59
Plausible(cancer, is common)
Evidence: 0.72
¬ Typical(skin cancer, be more common in later life)
0.27
Rule weight: 0.66
Evidence weight: 0.51
Similarity weight: 0.79
Evidence: 0.32
Plausible(illness, is common)
Evidence: 0.72
¬ Typical(skin cancer, be more common in later life)

Plausibility inheritance from parent to child

0.07
Rule weight: 0.09
Evidence weight: 0.91
Similarity weight: 0.79
Evidence: 0.72
Plausible(skin cancer, be more common in later life)
Evidence: 0.32
¬ Plausible(illness, is common)
0.06
Rule weight: 0.09
Evidence weight: 0.84
Similarity weight: 0.79
Evidence: 0.72
Plausible(skin cancer, be more common in later life)
Evidence: 0.59
¬ Plausible(cancer, is common)

Remarkability exclusitivity betweem a parent and a child

0.16
Rule weight: 0.58
Evidence weight: 0.34
Similarity weight: 0.79
Evidence: 0.75
¬ Remarkable(skin cancer, be more common in later life)
Evidence: 0.88
¬ Remarkable(illness, is common)
0.14
Rule weight: 0.58
Evidence weight: 0.31
Similarity weight: 0.79
Evidence: 0.75
¬ Remarkable(skin cancer, be more common in later life)
Evidence: 0.92
¬ Remarkable(cancer, is common)

Remarkability exclusitivity between siblings

0.06
Rule weight: 0.13
Evidence weight: 0.54
Similarity weight: 0.79
Evidence: 0.75
¬ Remarkable(skin cancer, be more common in later life)
Evidence: 0.62
¬ Remarkable(melanoma, is common)
0.04
Rule weight: 0.13
Evidence weight: 0.39
Similarity weight: 0.80
Evidence: 0.75
¬ Remarkable(skin cancer, be more common in later life)
Evidence: 0.81
¬ Remarkable(lung cancer, is most common)
0.03
Rule weight: 0.13
Evidence weight: 0.33
Similarity weight: 0.79
Evidence: 0.75
¬ Remarkable(skin cancer, be more common in later life)
Evidence: 0.90
¬ Remarkable(prostate cancer, is common)
0.03
Rule weight: 0.13
Evidence weight: 0.32
Similarity weight: 0.79
Evidence: 0.75
¬ Remarkable(skin cancer, be more common in later life)
Evidence: 0.90
¬ Remarkable(lung cancer, is common)

Remarkability from parent implausibility

0.31
Rule weight: 0.42
Evidence weight: 0.93
Similarity weight: 0.79
Evidence: 0.59
Plausible(cancer, is common)
Evidence: 0.75
Remarkable(skin cancer, be more common in later life)
Evidence: 0.72
¬ Plausible(skin cancer, be more common in later life)
0.29
Rule weight: 0.42
Evidence weight: 0.88
Similarity weight: 0.79
Evidence: 0.32
Plausible(illness, is common)
Evidence: 0.75
Remarkable(skin cancer, be more common in later life)
Evidence: 0.72
¬ Plausible(skin cancer, be more common in later life)

Remarkability from sibling implausibility

0.47
Rule weight: 0.60
Evidence weight: 0.99
Similarity weight: 0.79
Evidence: 0.72
Plausible(skin cancer, be more common in later life)
Evidence: 0.90
Remarkable(lung cancer, is common)
Evidence: 0.46
¬ Plausible(lung cancer, is common)
0.47
Rule weight: 0.60
Evidence weight: 0.99
Similarity weight: 0.79
Evidence: 0.72
Plausible(skin cancer, be more common in later life)
Evidence: 0.90
Remarkable(prostate cancer, is common)
Evidence: 0.44
¬ Plausible(prostate cancer, is common)
0.46
Rule weight: 0.60
Evidence weight: 0.96
Similarity weight: 0.80
Evidence: 0.72
Plausible(skin cancer, be more common in later life)
Evidence: 0.81
Remarkable(lung cancer, is most common)
Evidence: 0.70
¬ Plausible(lung cancer, is most common)
0.43
Rule weight: 0.60
Evidence weight: 0.91
Similarity weight: 0.79
Evidence: 0.72
Plausible(skin cancer, be more common in later life)
Evidence: 0.62
Remarkable(melanoma, is common)
Evidence: 0.86
¬ Plausible(melanoma, is common)

Salient implies Plausible

0.21
Rule weight: 0.28
Evidence weight: 0.76
Similarity weight: 1.00
Evidence: 0.72
Plausible(skin cancer, be more common in later life)
Evidence: 0.85
¬ Salient(skin cancer, be more common in later life)

Similarity expansion

0.69
Rule weight: 0.85
Evidence weight: 0.88
Similarity weight: 0.92
Evidence: 0.85
Salient(skin cancer, be more common in later life)
Evidence: 0.79
¬ Salient(skin cancer, be more common in life)
0.67
Rule weight: 0.85
Evidence weight: 0.85
Similarity weight: 0.92
Evidence: 0.72
Typical(skin cancer, be more common in later life)
Evidence: 0.54
¬ Typical(skin cancer, be more common in life)
0.65
Rule weight: 0.85
Evidence weight: 0.83
Similarity weight: 0.92
Evidence: 0.72
Plausible(skin cancer, be more common in later life)
Evidence: 0.60
¬ Plausible(skin cancer, be more common in life)
0.65
Rule weight: 0.85
Evidence weight: 0.88
Similarity weight: 0.86
Evidence: 0.85
Salient(skin cancer, be more common in later life)
Evidence: 0.81
¬ Salient(skin cancer, be more common in people)
0.63
Rule weight: 0.85
Evidence weight: 0.94
Similarity weight: 0.78
Evidence: 0.85
Salient(skin cancer, be more common in later life)
Evidence: 0.39
¬ Salient(skin cancer, be more common in people with lighter tone)
0.62
Rule weight: 0.85
Evidence weight: 0.89
Similarity weight: 0.82
Evidence: 0.85
Salient(skin cancer, be more common in later life)
Evidence: 0.76
¬ Salient(skin cancer, be more common in people with skin)
0.62
Rule weight: 0.85
Evidence weight: 0.93
Similarity weight: 0.79
Evidence: 0.72
Typical(skin cancer, be more common in later life)
Evidence: 0.26
¬ Typical(skin cancer, is common)
0.62
Rule weight: 0.85
Evidence weight: 0.79
Similarity weight: 0.92
Evidence: 0.75
Remarkable(skin cancer, be more common in later life)
Evidence: 0.83
¬ Remarkable(skin cancer, be more common in life)
0.61
Rule weight: 0.85
Evidence weight: 0.91
Similarity weight: 0.79
Evidence: 0.85
Salient(skin cancer, be more common in later life)
Evidence: 0.62
¬ Salient(skin cancer, be more common in people with tone)
0.61
Rule weight: 0.85
Evidence weight: 0.87
Similarity weight: 0.82
Evidence: 0.72
Typical(skin cancer, be more common in later life)
Evidence: 0.47
¬ Typical(skin cancer, be more common in people with skin)
0.61
Rule weight: 0.85
Evidence weight: 0.91
Similarity weight: 0.78
Evidence: 0.75
Remarkable(skin cancer, be more common in later life)
Evidence: 0.34
¬ Remarkable(skin cancer, be more common in people with lighter tone)
0.60
Rule weight: 0.85
Evidence weight: 0.88
Similarity weight: 0.80
Evidence: 0.85
Salient(skin cancer, be more common in later life)
Evidence: 0.78
¬ Salient(skin cancer, be more common in people with lighter skin)
0.60
Rule weight: 0.85
Evidence weight: 0.90
Similarity weight: 0.79
Evidence: 0.85
Salient(skin cancer, be more common in later life)
Evidence: 0.71
¬ Salient(skin cancer, is common)
0.60
Rule weight: 0.85
Evidence weight: 0.82
Similarity weight: 0.86
Evidence: 0.75
Remarkable(skin cancer, be more common in later life)
Evidence: 0.73
¬ Remarkable(skin cancer, be more common in people)
0.60
Rule weight: 0.85
Evidence weight: 0.81
Similarity weight: 0.86
Evidence: 0.72
Plausible(skin cancer, be more common in later life)
Evidence: 0.68
¬ Plausible(skin cancer, be more common in people)
0.60
Rule weight: 0.85
Evidence weight: 0.85
Similarity weight: 0.82
Evidence: 0.72
Plausible(skin cancer, be more common in later life)
Evidence: 0.55
¬ Plausible(skin cancer, be more common in people with skin)
0.60
Rule weight: 0.85
Evidence weight: 0.81
Similarity weight: 0.86
Evidence: 0.72
Typical(skin cancer, be more common in later life)
Evidence: 0.68
¬ Typical(skin cancer, be more common in people)
0.59
Rule weight: 0.85
Evidence weight: 0.87
Similarity weight: 0.80
Evidence: 0.85
Salient(skin cancer, be more common in later life)
Evidence: 0.86
¬ Salient(skin cancer, is most common)
0.59
Rule weight: 0.85
Evidence weight: 0.88
Similarity weight: 0.79
Evidence: 0.72
Plausible(skin cancer, be more common in later life)
Evidence: 0.44
¬ Plausible(skin cancer, is common)
0.59
Rule weight: 0.85
Evidence weight: 0.90
Similarity weight: 0.76
Evidence: 0.85
Salient(skin cancer, be more common in later life)
Evidence: 0.65
¬ Salient(skin cancer, be more prevalent today)
0.58
Rule weight: 0.85
Evidence weight: 0.86
Similarity weight: 0.79
Evidence: 0.75
Remarkable(skin cancer, be more common in later life)
Evidence: 0.54
¬ Remarkable(skin cancer, be more common in people with tone)
0.58
Rule weight: 0.85
Evidence weight: 0.87
Similarity weight: 0.78
Evidence: 0.72
Plausible(skin cancer, be more common in later life)
Evidence: 0.47
¬ Plausible(skin cancer, be more common in people with lighter tone)
0.57
Rule weight: 0.85
Evidence weight: 0.84
Similarity weight: 0.79
Evidence: 0.72
Plausible(skin cancer, be more common in later life)
Evidence: 0.57
¬ Plausible(skin cancer, be more common in people with tone)
0.57
Rule weight: 0.85
Evidence weight: 0.83
Similarity weight: 0.80
Evidence: 0.75
Remarkable(skin cancer, be more common in later life)
Evidence: 0.68
¬ Remarkable(skin cancer, be more common in people with lighter skin)
0.56
Rule weight: 0.85
Evidence weight: 0.82
Similarity weight: 0.80
Evidence: 0.72
Typical(skin cancer, be more common in later life)
Evidence: 0.63
¬ Typical(skin cancer, is most common)
0.56
Rule weight: 0.85
Evidence weight: 0.81
Similarity weight: 0.80
Evidence: 0.72
Plausible(skin cancer, be more common in later life)
Evidence: 0.67
¬ Plausible(skin cancer, be more common in people with lighter skin)
0.55
Rule weight: 0.85
Evidence weight: 0.85
Similarity weight: 0.76
Evidence: 0.72
Typical(skin cancer, be more common in later life)
Evidence: 0.51
¬ Typical(skin cancer, be more prevalent today)
0.55
Rule weight: 0.85
Evidence weight: 0.79
Similarity weight: 0.82
Evidence: 0.75
Remarkable(skin cancer, be more common in later life)
Evidence: 0.84
¬ Remarkable(skin cancer, be more common in people with skin)
0.55
Rule weight: 0.85
Evidence weight: 0.85
Similarity weight: 0.76
Evidence: 0.72
Plausible(skin cancer, be more common in later life)
Evidence: 0.53
¬ Plausible(skin cancer, be more prevalent today)
0.55
Rule weight: 0.85
Evidence weight: 0.82
Similarity weight: 0.79
Evidence: 0.72
Typical(skin cancer, be more common in later life)
Evidence: 0.64
¬ Typical(skin cancer, be more common in people with tone)
0.55
Rule weight: 0.85
Evidence weight: 0.81
Similarity weight: 0.80
Evidence: 0.72
Plausible(skin cancer, be more common in later life)
Evidence: 0.68
¬ Plausible(skin cancer, is most common)
0.55
Rule weight: 0.85
Evidence weight: 0.80
Similarity weight: 0.80
Evidence: 0.72
Typical(skin cancer, be more common in later life)
Evidence: 0.69
¬ Typical(skin cancer, be more common in people with lighter skin)
0.55
Rule weight: 0.85
Evidence weight: 0.82
Similarity weight: 0.78
Evidence: 0.72
Typical(skin cancer, be more common in later life)
Evidence: 0.62
¬ Typical(skin cancer, be more common in people with lighter tone)
0.54
Rule weight: 0.85
Evidence weight: 0.79
Similarity weight: 0.80
Evidence: 0.75
Remarkable(skin cancer, be more common in later life)
Evidence: 0.83
¬ Remarkable(skin cancer, is most common)
0.53
Rule weight: 0.85
Evidence weight: 0.82
Similarity weight: 0.76
Evidence: 0.75
Remarkable(skin cancer, be more common in later life)
Evidence: 0.72
¬ Remarkable(skin cancer, be more prevalent today)
0.52
Rule weight: 0.85
Evidence weight: 0.77
Similarity weight: 0.79
Evidence: 0.75
Remarkable(skin cancer, be more common in later life)
Evidence: 0.92
¬ Remarkable(skin cancer, is common)

Typical and Remarkable implies Salient

0.13
Rule weight: 0.14
Evidence weight: 0.92
Similarity weight: 1.00
Evidence: 0.85
Salient(skin cancer, be more common in later life)
Evidence: 0.72
¬ Typical(skin cancer, be more common in later life)
Evidence: 0.75
¬ Remarkable(skin cancer, be more common in later life)

Typical implies Plausible

0.38
Rule weight: 0.48
Evidence weight: 0.80
Similarity weight: 1.00
Evidence: 0.72
Plausible(skin cancer, be more common in later life)
Evidence: 0.72
¬ Typical(skin cancer, be more common in later life)

Typicality and Rermarkability incompatibility between a parent and a child

0.36
Rule weight: 0.51
Evidence weight: 0.89
Similarity weight: 0.79
Evidence: 0.75
¬ Remarkable(skin cancer, be more common in later life)
Evidence: 0.15
¬ Typical(illness, is common)
0.26
Rule weight: 0.51
Evidence weight: 0.64
Similarity weight: 0.79
Evidence: 0.75
¬ Remarkable(skin cancer, be more common in later life)
Evidence: 0.48
¬ Typical(cancer, is common)

Typicality and Rermarkability incompatibility between siblings

0.08
Rule weight: 0.14
Evidence weight: 0.79
Similarity weight: 0.79
Evidence: 0.75
¬ Remarkable(skin cancer, be more common in later life)
Evidence: 0.28
¬ Typical(prostate cancer, is common)
0.08
Rule weight: 0.14
Evidence weight: 0.78
Similarity weight: 0.79
Evidence: 0.75
¬ Remarkable(skin cancer, be more common in later life)
Evidence: 0.30
¬ Typical(lung cancer, is common)
0.06
Rule weight: 0.14
Evidence weight: 0.52
Similarity weight: 0.80
Evidence: 0.75
¬ Remarkable(skin cancer, be more common in later life)
Evidence: 0.64
¬ Typical(lung cancer, is most common)
0.03
Rule weight: 0.14
Evidence weight: 0.32
Similarity weight: 0.79
Evidence: 0.75
¬ Remarkable(skin cancer, be more common in later life)
Evidence: 0.91
¬ Typical(melanoma, is common)

Typicality inheritance from parent to child

0.37
Rule weight: 0.48
Evidence weight: 0.96
Similarity weight: 0.79
Evidence: 0.72
Typical(skin cancer, be more common in later life)
Evidence: 0.15
¬ Typical(illness, is common)
0.33
Rule weight: 0.48
Evidence weight: 0.86
Similarity weight: 0.79
Evidence: 0.72
Typical(skin cancer, be more common in later life)
Evidence: 0.48
¬ Typical(cancer, is common)